Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126047 · ClinicalTrials.gov registry record · NA
Exhaled Carbon Monoxide (eCO) for Diffusing Capacity (DLCO) Correction
A NA study of Lung Diseases, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT01126047: Completed NA study of Lung Diseases, sponsored by University of California, Los Angeles.
NCT01126047 is a NA study of Lung Diseases that has completed, run by University of California, Los Angeles. The registered enrollment target is 100 participants, below the 736-participant average among 31 other Lung Diseases trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01126047, a NA study of Lung Diseases, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to check the accuracy of a procedure called exhaled carbon monoxide (eCO) testing. Exhaled carbon monoxide is used by physicians to help assess breathing in people with conditions like asthma and emphysema. eCO may be used to correct another breathing test (called diffusing capacity, or DLCO). Blood collection is usually required to correct the DLCO, so validation of the eCO test may help avoid that blood collection.
Primary Outcome
Exhaled carbon monoxide will be evaluated as a predictor of carboxyhemoglobin and change in diffusing capacity with increasing carboxyhemoglobin
Conditions Studied
Interventions
- OTHER eCO testing
Study Locations (2)
California
- UCLA - Los Angeles
- West LA VA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-11 |
| Phase | NA |
What the finished NCT01126047 record still lists
NCT01126047 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 736-participant average among 31 other Lung Diseases trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Lung Diseases appearing as the primary indexed condition, and to 1 intervention - of which eCO testing is the first listed.
NCT01126047 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01126047 about?
NCT01126047 is a clinical study titled "Exhaled Carbon Monoxide (eCO) for Diffusing Capacity (DLCO) Correction". The purpose of this study is to check the accuracy of a procedure called exhaled carbon monoxide (eCO) testing. Exhaled carbon monoxide is used by physicians to help assess breathing in people with conditions like asthma and emphysema. eCO may be used to correct another breathing test (called diffus...
What is the current status of trial NCT01126047?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2010-05. Estimated completion is 2011-11.
What conditions does trial NCT01126047 study?
This clinical trial studies the following conditions: Lung Diseases.
What interventions are being tested in trial NCT01126047?
The interventions under investigation include: eCO testing (OTHER).
Who is sponsoring clinical trial NCT01126047?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01126047 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01126047's enrollment target sits among peer trials
100 24th of 31 higher than 6 of 31 other Lung Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Housing, Environment, And Living Conditions for Transformed Health
RECRUITING · NA
-
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
ACTIVE NOT RECRUITING · NA
-
Clinical Utility for Ion Endoluminal System
ACTIVE NOT RECRUITING · NA
-
Palliative Care Coaching for Families With Rare Advanced Lung Diseases
COMPLETED · NA
-
Environmental Tobacco Smoke Exposure Reduction in High-Risk Preteens
COMPLETED · NA
-
Influence of Data Collection Mode on Self-Report Validity of Asthma Therapy Adherence
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia